Research Site

Hammond, Louisiana 70403

2 studies enrolling now · 15 studies all time

What they study most

Acute Coronary Syndrome, Cardiovascular Disease, Crohn's Disease, Diabetes Mellitus, Non-Insulin-Dependent, Dyslipidemia, Heart Failure With Preserved Ejection Fraction, Heterozygous Familial Hypercholesterolaemia, High Risk for Cardiovascular Event, Multiple Sclerosis, Polycythemia Vera, Ulcerative Colitis

Studies at this site

• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS — Recruiting now
• A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH — Running, not enrolling
• A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event — Running, not enrolling
• Study to Assess SLN124 in Patients With Polycythemia Vera — Running, not enrolling
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk — Completed
• Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure. — Completed
• Dimethyl Fumarate (DMF) Observational Study — Completed
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension — Completed
• Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease — Stopped early
• Long-term Safety Study of Brodalumab in Adults With Crohn's Disease — Stopped early
• Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease. — Completed
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events — Completed
• Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis — Completed
• Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects — Completed